Scott Henry
Stock Analyst at Alliance Global Partners
(1.25)
# 3,601
Out of 5,182 analysts
58
Total ratings
38.46%
Success rate
-6.05%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $0.76 | +293.86% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $0.91 | +311.18% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $0.85 | +606.38% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $2.31 | +332.90% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $41 | $18.04 | +128.66% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $5.26 | +61.60% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $0.84 | +376.19% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $2.24 | +569.64% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $240 | $0.88 | +27,203.75% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $5.90 | +27.12% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $10.55 | +23.28% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $32.39 | -25.90% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $232.32 | -61.26% | 9 | Dec 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $29.44 | -47.35% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $112.40 | -48.40% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $84.49 | -57.39% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.05 | +947.62% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $3.89 | +54.24% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $0.73 | +783,278.75% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.19 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $0.82 | +752.51% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $12.71 | - | 5 | Apr 18, 2019 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $0.76
Upside: +293.86%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $0.91
Upside: +311.18%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $0.85
Upside: +606.38%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $2.31
Upside: +332.90%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $41
Current: $18.04
Upside: +128.66%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $5.26
Upside: +61.60%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $0.84
Upside: +376.19%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $2.24
Upside: +569.64%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $240
Current: $0.88
Upside: +27,203.75%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $5.90
Upside: +27.12%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $10.55
Upside: +23.28%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $32.39
Upside: -25.90%
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $232.32
Upside: -61.26%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $29.44
Upside: -47.35%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $112.40
Upside: -48.40%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $84.49
Upside: -57.39%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.05
Upside: +947.62%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $3.89
Upside: +54.24%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $0.73
Upside: +783,278.75%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.19
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $0.82
Upside: +752.51%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $12.71
Upside: -